title: Harnessing immune responses against Plasmodium for rational vaccine design.
abstract: In recent years, groundbreaking advances have been made in understanding the biology of and immune mechanisms against the Plasmodium spp. parasite, the causative agent of malaria. Novel features of the Plasmodium life cycle have been unravelled and immune mechanisms, which take place during both infection and immunization, have been dissected. We have undoubtedly enhanced our knowledge, but the question now is how to use this information to manipulate immune responses against Plasmodium and to develop an efficacious malaria vaccine. In this review, we discuss the latest developments in the field and speculate on how immune responses against Plasmodium could be harnessed for rational vaccine design and application.
authors.affiliation: Division of Immunology, Queensland Institute of Medical Research, Brisbane, Australia.
authors.forename: Bruno
authors.initials: B
authors.lastname: Douradinha
authors.forename: Denise L
authors.initials: DL
authors.lastname: Doolan
mesh_terms: D056704:Adaptive Immunity; D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000953:Antigens, Protozoan / Q000276:immunology; D015195:Drug Design; D006790:Host-Parasite Interactions; D006801:Humans; D056747:Immunomodulation; D008018:Life Cycle Stages; D008099:Liver / Q000469:parasitology; D008288:Malaria / Q000276:immunology* / Q000469:parasitology; D017780:Malaria Vaccines / Q000008:administration & dosage / Q000276:immunology*; D010961:Plasmodium / Q000254:growth & development / Q000276:immunology* / Q000502:physiology; D034101:Sporozoites / Q000276:immunology; D014162:Transfection
chemical_list: D000276:Adjuvants, Immunologic; D000953:Antigens, Protozoan; D017780:Malaria Vaccines